US Patent Issued to IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY), INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY on Aug. 25 for "Pharmaceutical composition containing HERES expression inhibitor for preventing or treating squamous cell carcinoma" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,066, issued on Aug. 25, was assigned to IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (Seoul, South Korea) and INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (Seoul, South Korea).

"Pharmaceutical composition containing HERES expression inhibitor for preventing or treating squamous cell carcinoma" was invented by Jin-Wu Nam (Seoul, South Korea), Bo-Hyun You (Seoul, South Korea), Sang Kil Lee (Seoul, South Korea) and Jung Ho Yoon (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to a pharmaceutical composition for preventing or treating squamous cell carcinoma, the...